Nomura Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.9M | Sell |
54,960
-8,018
| -13% | -$1.53M | 0.03% | 424 |
|
|
2026
Q1 | $11.5M | Sell |
62,978
-4,373
| -6% | -$806K | 0.03% | 411 |
|
|
2025
Q4 | $11.9M | Sell |
67,351
-18
| -0% | -$2.94K | 0.03% | 401 |
|
|
2025
Q3 | $9.44M | Buy |
67,369
+13,028
| +24% | +$1.76M | 0.02% | 448 |
|
|
2025
Q2 | $6.82M | Buy |
54,341
+555
| +1% | +$69.2K | 0.02% | 526 |
|
|
2025
Q1 | $7.36M | Buy |
53,786
+4,694
| +10% | +$671K | 0.02% | 494 |
|
|
2024
Q4 | $7.51M | Sell |
49,092
-211
| -0.4% | -$35.6K | 0.02% | 482 |
|
|
2024
Q3 | $9.56M | Sell |
49,303
-6,790
| -12% | -$1.42M | 0.03% | 418 |
|
|
2024
Q2 | $13M | Sell |
56,093
-13,951
| -20% | -$3.03M | 0.04% | 327 |
|
|
2024
Q1 | $15.1M | Sell |
70,044
-1,651
| -2% | -$387K | 0.05% | 301 |
|
|
2023
Q4 | $18.6M | Buy |
71,695
+1,495
| +2% | +$367K | 0.08% | 253 |
|
|
2023
Q3 | $18M | Sell |
70,200
-7,882
| -10% | -$2.11M | 0.08% | 248 |
|
|
2023
Q2 | $22.2M | Buy |
78,082
+16,835
| +27% | +$5.01M | 0.1% | 231 |
|
|
2023
Q1 | $17M | Sell |
61,247
-224
| -0.4% | -$62K | 0.09% | 249 |
|
|
2022
Q4 | $17M | Buy |
61,471
+20,683
| +51% | +$5.84M | 0.1% | 232 |
|
|
2022
Q3 | $10.9M | Sell |
40,788
-1,678
| -4% | -$356K | 0.07% | 295 |
|
|
2022
Q2 | $8.66M | Buy |
42,466
+2,668
| +7% | +$545K | 0.05% | 330 |
|
|
2022
Q1 | $8.38M | Sell |
39,798
-1,598
| -4% | -$348K | 0.05% | 360 |
|
|
2021
Q4 | $9.93M | Sell |
41,396
-7,843
| -16% | -$2.02M | 0.05% | 334 |
|
|
2021
Q3 | $13.9M | Sell |
49,239
-4,522
| -8% | -$1.48M | 0.08% | 251 |
|
|
2021
Q2 | $18.6M | Sell |
53,761
-94,274
| -64% | -$28.6M | 0.11% | 207 |
|
|
2021
Q1 | $41.4M | Buy |
148,035
+4,320
| +3% | +$1.17M | 0.26% | 91 |
|
|
2020
Q4 | $35.2M | Sell |
143,715
-4,749
| -3% | -$1.23M | 0.24% | 94 |
|
|
2020
Q3 | $42.1M | Sell |
148,464
-1,239
| -0.8% | -$346K | 0.32% | 72 |
|
|
2020
Q2 | $40.1M | Buy |
149,703
+82,136
| +122% | +$24.7M | 0.34% | 68 |
|
|
2020
Q1 | $21.4M | Buy |
67,567
+2,665
| +4% | +$809K | 0.22% | 95 |
|
|
2019
Q4 | $19.3M | Buy |
64,902
+3,790
| +6% | +$1.05M | 0.17% | 125 |
|
|
2019
Q3 | $14.2M | Sell |
61,112
-1,086
| -2% | -$253K | 0.14% | 162 |
|
|
2019
Q2 | $14.5M | Buy |
62,198
+2,658
| +4% | +$614K | 0.14% | 143 |
|
|
2019
Q1 | $14.1M | Sell |
59,540
-80,147
| -57% | -$25.2M | 0.14% | 145 |
|
|
2018
Q4 | $42M | Sell |
139,687
-83,747
| -37% | -$26.7M | 0.47% | 52 |
|
|
2018
Q3 | $78.9M | Sell |
223,434
-7,637
| -3% | -$2.63M | 0.77% | 24 |
|
|
2018
Q2 | $67.1M | Sell |
231,071
-2,770
| -1% | -$779K | 0.7% | 31 |
|
|
2018
Q1 | $64M | Buy |
233,841
+7,721
| +3% | +$2.4M | 0.7% | 33 |
|
|
2017
Q4 | $72M | Buy |
226,120
+31,644
| +16% | +$10.2M | 0.83% | 24 |
|
|
2017
Q3 | $60.9M | Buy |
194,476
+128,450
| +195% | +$38M | 0.79% | 28 |
|
|
2017
Q2 | $17.9M | Buy |
66,026
+978
| +2% | +$259K | 0.24% | 103 |
|
|
2017
Q1 | $17.8M | Sell |
65,048
-730
| -1% | -$206K | 0.25% | 102 |
|
|
2016
Q4 | $18.7M | Buy |
65,778
+1,313
| +2% | +$389K | 0.34% | 72 |
|
|
2016
Q3 | $20.2M | Sell |
64,465
-434
| -0.7% | -$129K | 0.36% | 69 |
|
|
2016
Q2 | $15.7M | Sell |
64,899
-1,064
| -2% | -$280K | 0.29% | 84 |
|
|
2016
Q1 | $17.2M | Buy |
65,963
+17,668
| +37% | +$4.67M | 0.33% | 79 |
|
|
2015
Q4 | $14.8M | Sell |
48,295
-1,541
| -3% | -$443K | 0.29% | 99 |
|
|
2015
Q3 | $14.5M | Buy |
49,836
+7,680
| +18% | +$2.54M | 0.29% | 95 |
|
|
2015
Q2 | $17M | Buy |
42,156
+8,389
| +25% | +$3.37M | 0.32% | 88 |
|
|
2015
Q1 | $14.3M | Buy |
33,767
+956
| +3% | +$377K | 0.25% | 111 |
|
|
2014
Q4 | $11.2M | Sell |
32,811
-878
| -3% | -$284K | 0.2% | 127 |
|
|
2014
Q3 | $11.1M | Buy |
33,689
+1,912
| +6% | +$630K | 0.2% | 123 |
|
|
2014
Q2 | $10M | Sell |
31,777
-8,510
| -21% | -$2.56M | 0.19% | 137 |
|
|
2014
Q1 | $12.3M | Buy |
40,287
+7,573
| +23% | +$2.4M | 0.23% | 115 |
|
|
2013
Q4 | $9.15M | Sell |
32,714
-372
| -1% | -$96.2K | 0.16% | 146 |
|
|
2013
Q3 | $7.97M | Sell |
33,086
-5,598
| -14% | -$1.25M | 0.15% | 156 |
|
|
2013
Q2 | $8.32M | Buy |
+38,684
| New | +$8.27M | 0.17% | 145 |
|
Other funds holding BIIB
Nomura Asset Management's BIIB Position: Q2 2026 in Review
Nomura Asset Management reduced its Biogen (BIIB) stake by 13% in Q2 2026, selling an estimated $1.53M and leaving 54,960 shares worth $11.9M. The position accounts for 0.03% of the portfolio, ranked #424.
Nomura Asset Management first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $78.9M in Q3 2018. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Nomura Asset Management held 54,960 shares of Biogen worth $11.9M as of Q2 2026.
- Nomura Asset Management sold 8,018 Biogen shares in Q2 2026, an estimated $1.53M.
- Biogen made up 0.03% of Nomura Asset Management's portfolio in Q2 2026, its #424 holding.
- Nomura Asset Management first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Nomura Asset Management's Biogen position peaked at $78.9M in Q3 2018.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.